NCT02839486View on ClinicalTrials.gov

Vancomycin and Cefoxitin During Pediatric Cardiopulmonary Bypass

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

December 20, 2017

Study Completion Date

July 1, 2019

Conditions
Congenital Heart Disease
Interventions
OTHER

vancomycin pharmacokinetics

vancomycin serial plasmatic and ultrafiltrate samples in order to assess plasmatic and ultrafiltrate drug concentrations

OTHER

cefoxitin pharmacokinetics

cefoxitin serial plasmatic and ultrafiltrate samples in order to assess plasmatic and ultrafiltrate drug concentrations

Trial Locations (1)

00165

Terapia Intenisva Cardiochirurgica, Roma

All Listed Sponsors
lead

Bambino Gesù Hospital and Research Institute

OTHER

NCT02839486 - Vancomycin and Cefoxitin During Pediatric Cardiopulmonary Bypass | Biotech Hunter | Biotech Hunter